Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07601022

Acute Heart Failure Registry

To evaluate the clinical utility of quantitative electrocardiography (Quantitative ECG, QCG) by analyzing its associations with clinical characteristics and laboratory findings in patients hospitalized with acute heart failure.

Recruiting

Interested in participating?

Request Info

Key information

Age range

19 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 19 years or older who were admitted to the Department of Cardiology for acute heart failure
  • NT-proBNP ≥300 pg/mL
  • Patients who underwent electrocardiography at least once

Exclusion criteria

  • History of congenital heart disease
  • Patients with a dominant electronic pacemaker rhythm
  • Patients with a heart rate >140 beats per minute or electrocardiograms with excessive noise

Treatment and study plan

Primary outcomes

  1. 1-year mortality

    Time frame: From enrollment to 1-year

Secondary outcomes

  1. LVEF change

    Time frame: From enrollment to 1-year

    LVEF change by echocardiography

Sponsors and collaborators

Lead sponsor

Jin Joo Park

Other

Registry information

Official study title

Clinical Utility of Quantitative Electrocardiography in Patients With Acute Heart Failure: A Prospective Observational Study

Acronym: B-AHF

Important dates

Study start
2026
Primary completion
2030
Study completion
2030
First posted
May 22, 2026
Registry last updated
Jun 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.